Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4543714
Max Phase: Preclinical
Molecular Formula: C41H51F2N7O8
Molecular Weight: 807.90
Molecule Type: Unknown
Associated Items:
ID: ALA4543714
Max Phase: Preclinical
Molecular Formula: C41H51F2N7O8
Molecular Weight: 807.90
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1ccc(NC(=O)N[C@@H](Cc2cc(F)cc(F)c2)C(=O)N[C@H]2COC(=O)[C@@H]3C[C@H](C)CN3C(=O)[C@H](C)NC(=O)[C@@H]3CCCCN3C(=O)[C@@H]3CCCN3C2=O)cc1C
Standard InChI: InChI=1S/C41H51F2N7O8/c1-22-14-34-40(56)58-21-31(46-35(51)30(18-26-16-27(42)19-28(43)17-26)47-41(57)45-29-11-10-23(2)24(3)15-29)38(54)49-13-7-9-33(49)39(55)48-12-6-5-8-32(48)36(52)44-25(4)37(53)50(34)20-22/h10-11,15-17,19,22,25,30-34H,5-9,12-14,18,20-21H2,1-4H3,(H,44,52)(H,46,51)(H2,45,47,57)/t22-,25-,30-,31-,32-,33-,34-/m0/s1
Standard InChI Key: JBABULRUFNVNMI-ZGDAMVGESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 807.90 | Molecular Weight (Monoisotopic): 807.3767 | AlogP: 2.47 | #Rotatable Bonds: 6 |
Polar Surface Area: 186.56 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 15 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 11.11 | CX Basic pKa: | CX LogP: 2.68 | CX LogD: 2.68 |
Aromatic Rings: 2 | Heavy Atoms: 58 | QED Weighted: 0.32 | Np Likeness Score: -0.26 |
1. (2018) Substituted urea depsipeptide analogs as activators of the clpp endopeptidase, |
Source(1):